AKASA vs Waystar (2026)
A specialist revenue cycle AI vendor against the clearinghouse network most hospitals already run. AKASA sells generative AI for the provider side of the revenue cycle: prebill coding and documentation review, a research assistant for revenue cycle staff, and agents that check authorization and claim status on payer portals. Its models are trained on clinical and financial data and fine tuned for each health system, with the company's own revenue cycle experts working in the loop. Waystar is a publicly traded revenue cycle platform that clears transactions for about one million providers. Its AltitudeAI layer adds denial prioritization, drafted appeal packages from payer specific templates and, since 2026, agentic features inside workflows. It added clinical documentation integrity and utilization management when it bought Iodine Software in October 2025. If you want prebill coding and documentation review from a specialist, start with AKASA. If you want AI inside the claims network you already use, start with Waystar.
- Prebill review from one specialist: Coding Optimizer finds missed coding opportunities and compliance risks, and CDI Optimizer finds documentation gaps before the claim goes out.
- Models fine tuned for each health system, with AKASA's own revenue cycle experts working in the loop.
- Named deployments: Cleveland Clinic is rolling out the coding and documentation tools across its US locations, and Montage Health and Methodist Health System are named in case studies.
- The network is the product: claims, eligibility and payment transactions for about one million providers, with integrations to more than 500 record and practice management systems.
- AI across the cycle inside the platform: denial prioritization by expected value, drafted appeal packages, medical necessity summaries for authorizations and a billing assistant for patients.
- Attestations stated in a public filing: HITRUST, SOC 2 Type II and PCI DSS Level 1, and a HIPAA covered entity for its clearinghouse services.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Waystar are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AKASA | Waystar |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Founded | Not recorded | 2017 |
| Headquarters | South San Francisco, California | Lehi, Utah and Louisville, Kentucky |
| Website | akasa.com | waystar.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
AKASA
-
Product / capability
AKASA launched an autonomous platform for inpatient medical coding and clinical documentation integrity, building on its AI prebill review products.
Source
Waystar
-
Product / capability
Waystar launched agentic AI capabilities inside its AltitudeAI platform, moving from software that scores and routes work to agents that carry the work out.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AKASA, formerly Alpha Health, sells generative AI for the provider side of the revenue cycle to hospitals and health systems. Its listed solutions are the Prebill Optimization Suite, which combines Coding Optimizer (missed coding opportunities, quality and compliance risks) and CDI Optimizer (documentation gaps for clinical documentation integrity teams); AI Advisor, a research assistant for revenue cycle staff; Auth Status, which checks pending prior authorization requests on payer portals and records the results; and Claim Status, which does the same for outstanding claims.
Source: AI Health Index, September 2026
Waystar's AltitudeAI capabilities on its healthcare revenue cycle platform, which clears claims, eligibility and payment transactions for about one million providers and roughly 60 percent of US patients.
Source: AI Health Index, September 2026
Questions buyers ask
How do AKASA and Waystar work with the EHR?
AKASA's Montage Health case studies describe claim and authorization status automation working alongside Epic, returning detailed status information into the record to drive follow-up, and reducing an Epic authorization work queue by 22 percent.
With Waystar, the Innovation Lab adds FHIR-based prior authorization connectivity for CMS-0057-F. A 2023 third-party survey reports 94 percent of clients satisfied with its EHR integrations. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
How are AKASA and Waystar priced and sold?
AKASA sells to hospitals and health systems by solution, each with its own demo request. The platform page describes a dedicated account manager, production reporting, and the option of AKASA's own revenue cycle experts taking over workflows rather than staff using the tools, a service component that will shape the cost.
Waystar's annual report on Form 10-K says contracts generally combine a subscription fee with a volume-based component, sometimes only one; initial terms run two or three years and renew automatically for one-year terms with standard price escalators; billing is monthly; and more than 99 percent of revenue is recurring subscription or predictable volume. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
How do AKASA and Waystar handle patient data?
With AKASA, the data is complete clinical and financial documentation for whole health systems. Safety engineering, meaning guardrails, hallucination mitigation and how a safety event is handled, is not described.
In Waystar's case, the website privacy policy covers site visitors, keeping web analytics data 24 months and no longer than five years, and says support staff are trained and bound by confidentiality. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
Which settings and specialties do AKASA and Waystar cover?
AKASA sells to hospitals and health systems, states a client base of 500 hospitals across all 50 states, and covers coding and documentation integrity before billing, prior authorization status, claim status and a research assistant for revenue cycle staff.
With Waystar, the company's filing reports more than 30,000 client organizations and about one million providers, with revenue split roughly 30 percent hospitals and health systems to 70 percent ambulatory and alternate sites. The AI features run across that platform; results specific to them are not broken out by setting. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 25, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Both records were reviewed on this site in September 2026. The two now meet on clinical documentation integrity: AKASA through CDI Optimizer, Waystar through the Iodine line it bought in 2025.
AKASA states SOC 2, announced HITRUST r2 certification in 2022, hosts on AWS and publishes no price. It publishes customer results for its status agents, such as 71.3 percent of accounts cleared from work queues at Methodist. Both companies' scale figures are their own. Ask each for the rate at which coders accept its suggestions, and what happens to the rest.